מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
Life Healthcare Pty Ltd
Class III
Gelita Medical GmbH Uferstrasse 7, Eberbach, 69412 Germany
48170 - Gelatin haemostatic agent
Following application of the sponge to the surface of the defect or insertion into the surgically created void, the sponge results in rapid haemostasis by concentrating blood platelets and coagulating factors released by surgically/trauma-induced venous or diffuse oozing haemorrhage within the gelatin matrix. The shape and size of the defect determines the sponge configuration most suited to the operative site. To achieve rapid haemostasis by tamponade effect.
A
2008-09-16